Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Free Tissue Flaps | 5 | 2025 | 45 | 2.000 |
Why?
|
| Head and Neck Neoplasms | 6 | 2025 | 562 | 1.310 |
Why?
|
| Otolaryngology | 4 | 2020 | 108 | 1.290 |
Why?
|
| Laryngectomy | 2 | 2020 | 16 | 1.190 |
Why?
|
| Developing Countries | 2 | 2019 | 318 | 0.960 |
Why?
|
| Vocal Cord Paralysis | 1 | 2024 | 27 | 0.850 |
Why?
|
| Esophagus | 1 | 2024 | 261 | 0.720 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 2 | 2023 | 37 | 0.660 |
Why?
|
| Surgical Flaps | 2 | 2018 | 142 | 0.610 |
Why?
|
| Zenker Diverticulum | 3 | 2023 | 12 | 0.580 |
Why?
|
| Education, Medical, Graduate | 3 | 2022 | 557 | 0.570 |
Why?
|
| Mouth Neoplasms | 1 | 2019 | 90 | 0.550 |
Why?
|
| Drug Therapy | 1 | 2018 | 80 | 0.530 |
Why?
|
| Laryngeal Neoplasms | 1 | 2017 | 35 | 0.530 |
Why?
|
| Simulation Training | 1 | 2020 | 134 | 0.520 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2018 | 222 | 0.520 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2022 | 642 | 0.500 |
Why?
|
| Surgical Procedures, Operative | 1 | 2018 | 271 | 0.450 |
Why?
|
| Postoperative Care | 1 | 2015 | 288 | 0.390 |
Why?
|
| Neck | 3 | 2025 | 108 | 0.390 |
Why?
|
| Graft Survival | 1 | 2015 | 526 | 0.380 |
Why?
|
| Attitude of Health Personnel | 1 | 2020 | 1186 | 0.360 |
Why?
|
| Wounds and Injuries | 1 | 2018 | 957 | 0.310 |
Why?
|
| Skull Base | 2 | 2018 | 54 | 0.280 |
Why?
|
| Paranasal Sinuses | 2 | 2018 | 81 | 0.270 |
Why?
|
| Printing, Three-Dimensional | 2 | 2018 | 96 | 0.250 |
Why?
|
| Esophagoscopy | 2 | 2024 | 221 | 0.230 |
Why?
|
| Deltoid Muscle | 1 | 2025 | 6 | 0.220 |
Why?
|
| Fishes | 1 | 2024 | 108 | 0.200 |
Why?
|
| Arteries | 1 | 2025 | 259 | 0.190 |
Why?
|
| Humans | 23 | 2025 | 144957 | 0.190 |
Why?
|
| Foreign Bodies | 1 | 2024 | 107 | 0.190 |
Why?
|
| Diverticulum, Esophageal | 1 | 2022 | 4 | 0.190 |
Why?
|
| Diverticulum | 1 | 2022 | 14 | 0.190 |
Why?
|
| Pharyngeal Diseases | 1 | 2022 | 16 | 0.190 |
Why?
|
| Endoscopy | 3 | 2020 | 316 | 0.190 |
Why?
|
| Esophageal Diseases | 1 | 2022 | 30 | 0.180 |
Why?
|
| Musculoskeletal Pain | 1 | 2023 | 43 | 0.180 |
Why?
|
| Muscular Diseases | 1 | 2022 | 108 | 0.180 |
Why?
|
| Cadaver | 2 | 2020 | 304 | 0.180 |
Why?
|
| Musculoskeletal Diseases | 1 | 2023 | 90 | 0.170 |
Why?
|
| Models, Anatomic | 2 | 2018 | 84 | 0.170 |
Why?
|
| Osteoradionecrosis | 1 | 2021 | 4 | 0.170 |
Why?
|
| Head | 2 | 2020 | 120 | 0.170 |
Why?
|
| Occupational Diseases | 1 | 2023 | 165 | 0.170 |
Why?
|
| Tooth Extraction | 1 | 2021 | 28 | 0.170 |
Why?
|
| Nasal Bone | 1 | 2020 | 3 | 0.160 |
Why?
|
| Zygomatic Fractures | 1 | 2020 | 3 | 0.160 |
Why?
|
| Peritonsillar Abscess | 1 | 2020 | 4 | 0.160 |
Why?
|
| Lacrimal Apparatus | 1 | 2020 | 9 | 0.160 |
Why?
|
| Epistaxis | 1 | 2020 | 17 | 0.160 |
Why?
|
| Skull Fractures | 1 | 2020 | 35 | 0.150 |
Why?
|
| Bronchoscopy | 1 | 2020 | 227 | 0.140 |
Why?
|
| Postoperative Period | 1 | 2019 | 354 | 0.140 |
Why?
|
| Nerve Block | 1 | 2020 | 103 | 0.140 |
Why?
|
| Tracheostomy | 1 | 2020 | 142 | 0.140 |
Why?
|
| Dermatologic Surgical Procedures | 1 | 2017 | 21 | 0.130 |
Why?
|
| Aged | 5 | 2025 | 25947 | 0.130 |
Why?
|
| SEER Program | 1 | 2017 | 224 | 0.120 |
Why?
|
| Prospective Studies | 4 | 2023 | 7997 | 0.120 |
Why?
|
| Social Class | 1 | 2018 | 268 | 0.120 |
Why?
|
| Geriatric Assessment | 1 | 2018 | 233 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2024 | 2738 | 0.120 |
Why?
|
| Face | 1 | 2017 | 174 | 0.120 |
Why?
|
| Female | 8 | 2025 | 78376 | 0.110 |
Why?
|
| Velopharyngeal Insufficiency | 1 | 2015 | 15 | 0.110 |
Why?
|
| Hospitals | 1 | 2019 | 732 | 0.110 |
Why?
|
| Poverty | 1 | 2018 | 530 | 0.110 |
Why?
|
| Speech | 1 | 2015 | 77 | 0.110 |
Why?
|
| Survival Analysis | 1 | 2017 | 1385 | 0.100 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 1465 | 0.100 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 289 | 0.100 |
Why?
|
| Pandemics | 1 | 2022 | 1695 | 0.100 |
Why?
|
| Survival Rate | 1 | 2017 | 2092 | 0.090 |
Why?
|
| Cohort Studies | 4 | 2025 | 5965 | 0.090 |
Why?
|
| Male | 6 | 2025 | 72406 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1563 | 0.080 |
Why?
|
| Retrospective Studies | 4 | 2025 | 17101 | 0.070 |
Why?
|
| Adult | 4 | 2025 | 40506 | 0.070 |
Why?
|
| Quality of Life | 1 | 2018 | 3192 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 8279 | 0.060 |
Why?
|
| Middle Aged | 4 | 2025 | 35928 | 0.060 |
Why?
|
| United States | 2 | 2020 | 15988 | 0.050 |
Why?
|
| Ergonomics | 1 | 2023 | 29 | 0.050 |
Why?
|
| Esophageal Sphincter, Upper | 1 | 2022 | 8 | 0.050 |
Why?
|
| Mandibular Osteotomy | 1 | 2021 | 3 | 0.040 |
Why?
|
| Teriparatide | 1 | 2021 | 10 | 0.040 |
Why?
|
| Clinical Competence | 2 | 2020 | 1244 | 0.040 |
Why?
|
| Proton Therapy | 1 | 2021 | 15 | 0.040 |
Why?
|
| Ultrasonic Therapy | 1 | 2021 | 16 | 0.040 |
Why?
|
| Mandible | 1 | 2021 | 72 | 0.040 |
Why?
|
| Microsurgery | 1 | 2020 | 72 | 0.040 |
Why?
|
| Radiotherapy Dosage | 1 | 2021 | 289 | 0.040 |
Why?
|
| Bone Density Conservation Agents | 1 | 2021 | 81 | 0.040 |
Why?
|
| B7-H1 Antigen | 1 | 2022 | 241 | 0.040 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2021 | 142 | 0.040 |
Why?
|
| Ozone | 1 | 2021 | 132 | 0.040 |
Why?
|
| Advisory Committees | 1 | 2020 | 230 | 0.040 |
Why?
|
| Consensus | 1 | 2021 | 489 | 0.040 |
Why?
|
| Neuronavigation | 1 | 2018 | 8 | 0.040 |
Why?
|
| Internship and Residency | 2 | 2020 | 1257 | 0.040 |
Why?
|
| Fellowships and Scholarships | 1 | 2022 | 357 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2018 | 170 | 0.030 |
Why?
|
| Neurosurgical Procedures | 1 | 2018 | 202 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2020 | 901 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2020 | 949 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 1141 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 2947 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2023 | 11695 | 0.030 |
Why?
|
| Incidence | 1 | 2021 | 2883 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2018 | 1095 | 0.030 |
Why?
|
| Curriculum | 1 | 2020 | 1060 | 0.020 |
Why?
|
| Reoperation | 1 | 2015 | 631 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 6053 | 0.020 |
Why?
|
| Risk Factors | 1 | 2021 | 10792 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2015 | 11799 | 0.010 |
Why?
|
| Adolescent | 1 | 2015 | 22453 | 0.010 |
Why?
|
| Child | 1 | 2015 | 22657 | 0.010 |
Why?
|